3.57
Third Harmonic Bio Inc (THRD) 最新ニュース
Fierce Biotech Layoff Tracker 2025: Sail cuts staff; Carisma and Inspirna shutter - Fierce Biotech
Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks
Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace
Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks
Stifel Downgrades Third Harmonic Bio (THRD) - MSN
Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener
Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks
Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks
Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com
Third Harmonic Bio Q4 Net Income USD -13.1 Million - Marketscreener.com
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Third Harmonic Bio, Inc. Announces Rise In Full Year Profit - Nasdaq
Third Harmonic's $285M War Chest Powers Phase 2 CSU Drug Development Amid Strategic Shift - Stock Titan
Third Harmonic Bio Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
2025 R&D layoffs tracker: 53,686 and counting - R&D World
Third Harmonic Bio Advances THB335 for Inflammatory Diseases - TipRanks
THB-335 counteracts cutaneous anaphylaxis in vivo - BioWorld Online
Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Finance Watch: BridgeBio’s Oncology Spinout Reveals Go-Public Plan - Citeline
IPOs Numbers Rise In 2024, But Dwindling Returns Could Diminish Potential In 2025 - Scrip
Companies Like Third Harmonic Bio (NASDAQ:THRD) Are In A Position To Invest In Growth - Yahoo Finance
Third Harmonic Bio downgraded to Market Perform from Outperform at Raymond James - MSN
Third Harmonic Bio progresses THB335 to Phase 2 trial - MSN
Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD) - Nasdaq
Third Harmonic stock rating cut by Raymond James - MSN
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study - Yahoo Finance
大文字化:
|
ボリューム (24 時間):